New antibody drug tested for patients Who've run out of options
Disease control
ENROLLING_BY_INVITATION
This study is testing whether adding a new antibody drug called HuL001 to standard medications (lenalidomide and dexamethasone) can help control multiple myeloma that has returned or stopped responding to previous treatments. The trial will enroll 21 patients who have already tri…
Phase: PHASE1, PHASE2 • Sponsor: HuniLife Biotechnology, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC